Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Maybridge
Maybridge
Activities:
Ingredients
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
US court lifts modified consent decree on Xellia’s Cleveland facility
The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
Lonza's AI-enabled small molecule development tool launches
The company's AI-enabled Route Scouting Service will optimise synthetic route identification when identifying novel APIs
Autoscribe Informatics’ new Australia office supports business growth
The company's move to West Lakes Adelaide expands its ability to service the Asia Pacific region in digitalising laboratory information
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Ingredients
Thermo Fisher Scientific introduces ‘off the shelf’ fragment library
Maybridge Ro3 Diversity Fragments now available in prepared stock solution format for convenient use at the bench top
Research & Development
Thermo Fisher to highlight Maybridge solutions at Fragments III
Maybridge scientists to exhibit fragment collections and present research poster
Research & Development
Thermo Fisher Scientific screening collection helps identify promising compound
University of Minnesota Bernlohr Group employs Maybridge HitFinder collection in FABP inhibitor research
Research & Development
Thermo Fisher Scientific screening compound collection goes interactive
Complete Maybridge HitFinder pre-selected diverse screening library now available online
Speed up the drug discovery process with quick building block kits
<p>Maybridge, part of Thermo Fisher Scientific, has introduced a novel tool to accelerate hit-to-lead programmes in the drug discovery process. </p>
Fisher Scientific acquires Maybridge
Maybridge, a leading UK-based supplier of organic compounds and screening libraries, has been acquired by Fisher Scientific International, of the US.
Collaboration on lead optimisation
Subscribe now